Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo

Abstract A major number of studies have demonstrated Beta-tricalcium phosphate (β-TCP) biocompatibility, bioactivity, and osteoconductivity characteristics in bone regeneration. The aim of this research was to enhance β-TCP's biocompatibility, and evaluate its physicochemical properties by argo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheuk Sing Choy, Wei Fang Lee, Pei Ying Lin, Yi-Fan Wu, Haw-Ming Huang, Nai-Chia Teng, Yu-Hwa Pan, Eisner Salamanca, Wei-Jen Chang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e08eb2d119ba46449f5cc92464441534
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e08eb2d119ba46449f5cc92464441534
record_format dspace
spelling oai:doaj.org-article:e08eb2d119ba46449f5cc924644415342021-12-02T16:55:24ZSurface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo10.1038/s41598-021-88402-52045-2322https://doaj.org/article/e08eb2d119ba46449f5cc924644415342021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88402-5https://doaj.org/toc/2045-2322Abstract A major number of studies have demonstrated Beta-tricalcium phosphate (β-TCP) biocompatibility, bioactivity, and osteoconductivity characteristics in bone regeneration. The aim of this research was to enhance β-TCP's biocompatibility, and evaluate its physicochemical properties by argon glow discharge plasma (GDP) plasma surface treatment without modifying its surface. Treated β-TCP was analyzed by scanning electron microscopy (SEM), energy-dispersive spectrometry, X-ray photoelectron spectroscopy (XPS), X-ray diffraction analysis, and Fourier transform infrared spectroscopy characterization. To evaluate treated β-TCP biocompatibility and osteoblastic differentiation, water-soluble tetrazolium salts-1 (WST-1), immunofluorescence, alkaline phosphatase (ALP) assay, and quantitative real-time polymerase chain reaction (QPCR) were done using human mesenchymal stem cells (hMSCs). The results indicated a slight enhancement of the β-TCP by GDP sputtering, which resulted in a higher Ca/P ratio (2.05) than the control. Furthermore, when compared with control β-TCP, we observed an improvement of WST-1 on all days (p < 0.05) as well as of ALP activity (day 7, p < 0.05), with up-regulation of ALP, osteocalcin, and Osteoprotegerin osteogenic genes in cells cultured with the treated β-TCP. XPS and SEM results indicated that treated β-TCP’s surface was not modified. In vivo, micro-computed tomography and histomorphometric analysis indicated that the β-TCP test managed to regenerate more new bone than the untreated β-TCP and control defects at 8 weeks (p < 0.05). Argon GDP treatment is a viable method for removing macro and micro particles of < 7 μm in size from β-TCP bigger particles surfaces and therefore improving its biocompatibility with slight surface roughness modification, enhancing hMSCs proliferation, osteoblastic differentiation, and stimulating more new bone formation.Cheuk Sing ChoyWei Fang LeePei Ying LinYi-Fan WuHaw-Ming HuangNai-Chia TengYu-Hwa PanEisner SalamancaWei-Jen ChangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cheuk Sing Choy
Wei Fang Lee
Pei Ying Lin
Yi-Fan Wu
Haw-Ming Huang
Nai-Chia Teng
Yu-Hwa Pan
Eisner Salamanca
Wei-Jen Chang
Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
description Abstract A major number of studies have demonstrated Beta-tricalcium phosphate (β-TCP) biocompatibility, bioactivity, and osteoconductivity characteristics in bone regeneration. The aim of this research was to enhance β-TCP's biocompatibility, and evaluate its physicochemical properties by argon glow discharge plasma (GDP) plasma surface treatment without modifying its surface. Treated β-TCP was analyzed by scanning electron microscopy (SEM), energy-dispersive spectrometry, X-ray photoelectron spectroscopy (XPS), X-ray diffraction analysis, and Fourier transform infrared spectroscopy characterization. To evaluate treated β-TCP biocompatibility and osteoblastic differentiation, water-soluble tetrazolium salts-1 (WST-1), immunofluorescence, alkaline phosphatase (ALP) assay, and quantitative real-time polymerase chain reaction (QPCR) were done using human mesenchymal stem cells (hMSCs). The results indicated a slight enhancement of the β-TCP by GDP sputtering, which resulted in a higher Ca/P ratio (2.05) than the control. Furthermore, when compared with control β-TCP, we observed an improvement of WST-1 on all days (p < 0.05) as well as of ALP activity (day 7, p < 0.05), with up-regulation of ALP, osteocalcin, and Osteoprotegerin osteogenic genes in cells cultured with the treated β-TCP. XPS and SEM results indicated that treated β-TCP’s surface was not modified. In vivo, micro-computed tomography and histomorphometric analysis indicated that the β-TCP test managed to regenerate more new bone than the untreated β-TCP and control defects at 8 weeks (p < 0.05). Argon GDP treatment is a viable method for removing macro and micro particles of < 7 μm in size from β-TCP bigger particles surfaces and therefore improving its biocompatibility with slight surface roughness modification, enhancing hMSCs proliferation, osteoblastic differentiation, and stimulating more new bone formation.
format article
author Cheuk Sing Choy
Wei Fang Lee
Pei Ying Lin
Yi-Fan Wu
Haw-Ming Huang
Nai-Chia Teng
Yu-Hwa Pan
Eisner Salamanca
Wei-Jen Chang
author_facet Cheuk Sing Choy
Wei Fang Lee
Pei Ying Lin
Yi-Fan Wu
Haw-Ming Huang
Nai-Chia Teng
Yu-Hwa Pan
Eisner Salamanca
Wei-Jen Chang
author_sort Cheuk Sing Choy
title Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
title_short Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
title_full Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
title_fullStr Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
title_full_unstemmed Surface Modified β-Tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
title_sort surface modified β-tricalcium phosphate enhanced stem cell osteogenic differentiation in vitro and bone regeneration in vivo
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e08eb2d119ba46449f5cc92464441534
work_keys_str_mv AT cheuksingchoy surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT weifanglee surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT peiyinglin surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT yifanwu surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT hawminghuang surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT naichiateng surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT yuhwapan surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT eisnersalamanca surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
AT weijenchang surfacemodifiedbtricalciumphosphateenhancedstemcellosteogenicdifferentiationinvitroandboneregenerationinvivo
_version_ 1718382891701895168